GC
COLL icon

Globeflex Capital’s Collegium Pharmaceutical COLL Stock Holding History

Globeflex Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Sell
52,911
-44
-0.1% -$1.5K 0.24% 112
2026
Q1 		$1.75M Hold
52,955
– – 0.27% 103
2025
Q4 		$2.45M Hold
52,955
– – 0.38% 82
2025
Q3 		$1.85M Buy
52,955
+44
+0.1% +$1.53K 0.29% 100
2025
Q2 		$1.56M Hold
52,911
– – 0.13% 141
2025
Q1 		$1.58M Hold
52,911
– – 0.15% 127
2024
Q4 		$1.52M Hold
52,911
– – 0.13% 136
2024
Q3 		$2.04M Sell
52,911
-27
-0.1% -$963 0.2% 114
2024
Q2 		$1.7M Sell
52,938
-7,132
-12% -$247K 0.18% 122
2024
Q1 		$2.33M Buy
60,070
+15,827
+36% +$554K 0.23% 111
2023
Q4 		$1.36M Hold
44,243
– – 0.14% 150
2023
Q3 		$989K Sell
44,243
-1,223
-3% -$27.9K 0.12% 174
2023
Q2 		$977K Sell
45,466
-1,783
-4% -$40.5K 0.11% 178
2023
Q1 		$1.13M Hold
47,249
– – 0.14% 167
2022
Q4 		$1.1M Hold
47,249
– – 0.14% 172
2022
Q3 		$757K Hold
47,249
– – 0.13% 203
2022
Q2 		$837K Hold
47,249
– – 0.2% 146
2022
Q1 		$962K Hold
47,249
– – 0.2% 147
2021
Q4 		$883K Hold
47,249
– – 0.18% 174
2021
Q3 		$933K Hold
47,249
– – 0.2% 158
2021
Q2 		$1.12M Hold
47,249
– – 0.2% 179
2021
Q1 		$1.12M Sell
47,249
-18,212
-28% -$433K 0.2% 168
2020
Q4 		$1.31M Sell
65,461
-35,668
-35% -$696K 0.28% 108
2020
Q3 		$2.11M Buy
101,129
+1,879
+2% +$33.9K 0.56% 30
2020
Q2 		$1.74M Buy
99,250
+944
+1% +$18.5K 0.44% 44
2020
Q1 		$1.6M Buy
98,306
+11,376
+13% +$235K 0.49% 36
2019
Q4 		$1.79M Buy
86,930
+1,854
+2% +$30.9K 0.34% 76
2019
Q3 		$977K Hold
85,076
– – 0.21% 158
2019
Q2 		$1.12M Buy
+85,076
New +$1.14M 0.23% 132

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Globeflex Capital's COLL Position: Q2 2026 in Review

Globeflex Capital reduced its Collegium Pharmaceutical (COLL) stake by 0.08% in Q2 2026, selling an estimated $1.5K and leaving 52,911 shares worth $1.92M. The position accounts for 0.24% of the portfolio, ranked #112.

Globeflex Capital first reported a position in COLL in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.45M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Globeflex Capital held 52,911 shares of Collegium Pharmaceutical worth $1.92M as of Q2 2026.
  • Globeflex Capital sold 44 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.5K.
  • Collegium Pharmaceutical made up 0.24% of Globeflex Capital's portfolio in Q2 2026, its #112 holding.
  • Globeflex Capital first reported a position in Collegium Pharmaceutical in Q2 2019 and has held it in 29 quarters since.
  • Globeflex Capital's Collegium Pharmaceutical position peaked at $2.45M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.